- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hepion Pharmaceuticals Inc (HEPA)
Track today's live Hepion Pharmaceuticals (HEPA) share price, performance and key data on this page with our current OTC Markets:HEPA stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Hepion Pharmaceuticals share price on the OTC Markets exchange. Use the dropdown to switch exchange for the HEPA share price, head to our technical summary section, which provides analysis on Hepion Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Hepion Pharmaceuticals (HEPA) stock price today with other investors in the Hepion Pharmaceuticals OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC:HEPA share price (ISIN: US4268974015) to enhance your trading decisions with our free investment tools and resources.
What Is the Hepion Pharmaceuticals Inc Share Price Today?
The Hepion Pharmaceuticals share price today is 0.066.
What Is the Stock Symbol for Hepion Pharmaceuticals Inc
The stock symbol (or 'ticker') for Hepion Pharmaceuticals Inc is "HEPA."
What Stock Exchange Does Hepion Pharmaceuticals Inc Trade On?
Hepion Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Hepion Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Hepion Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current OTC:HEPA share price (ISIN: US4268974015) to enhance your trading decisions with our free investment tools and resources.
What Is the Hepion Pharmaceuticals Inc Share Price Today?
The Hepion Pharmaceuticals share price today is 0.066.
What Is the Stock Symbol for Hepion Pharmaceuticals Inc
The stock symbol (or 'ticker') for Hepion Pharmaceuticals Inc is "HEPA."
What Stock Exchange Does Hepion Pharmaceuticals Inc Trade On?
Hepion Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Hepion Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Hepion Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
0.066
-0.005(-7.04%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.066
0.083
52 wk Range
0.034
0.110
HEPA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0660.083
52 wk Range
0.0340.110
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HEPA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
13/08/2026
EPS / Forecast
-0.08 / --
Revenue / Forecast
-- / --
Compare HEPA to Peers and Sector
Metrics to compare | HEPA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHEPAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −7.2x | −0.4x | |
PEG Ratio | −0.02 | −0.01 | 0.00 | |
Price/Book | −14.3x | −7.8x | 2.6x | |
Price / LTM Sales | - | 5.9x | 3.1x | |
Upside (Analyst Target) | - | 58.5% | 49.6% | |
Fair Value Upside | Unlock | −5.9% | 7.1% | Unlock |
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, and HDV. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Hepion Pharmaceuticals (OTC Markets: HEPA) Share Price Today?
The Hepion Pharmaceuticals stock price today is 0.066 USD.
What Stock Exchange Does Hepion Pharmaceuticals (HEPA) Trade On?
Hepion Pharmaceuticals is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for Hepion Pharmaceuticals?
The stock symbol (also called a 'ticker') for Hepion Pharmaceuticals is "HEPA."
What Is the Current Hepion Pharmaceuticals Market Capitalisation?
As of today, Hepion Pharmaceuticals (OTC Markets: HEPA) market cap is 5.950M USD.
What Is Hepion Pharmaceuticals's (HEPA) Earnings Per Share (TTM)?
The Hepion Pharmaceuticals EPS is currently -0.249 (Trailing Twelve Months).
Is HEPA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Hepion Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for HEPA stock is Neutral.
How Many Times Has Hepion Pharmaceuticals Stock Split?
Hepion Pharmaceuticals has split 4 times. (See the HEPA stock split history page for full effective split date and price information.)
How Many Employees Does Hepion Pharmaceuticals Have?
Hepion Pharmaceuticals has 2 employees, based on their latest Companies House report.
What is the current trading status of Hepion Pharmaceuticals (OTC Markets: HEPA)?
As of 04/09/2026, Hepion Pharmaceuticals (HEPA) is trading at a share price of 0.066 USD, with a previous close of 0.066 USD. The stock has fluctuated within a day range of 0.066 USD to 0.083 USD, while its 52-week range spans from 0.034 USD to 0.110 USD.
What Is the HEPA After Hours Price?
HEPA's last after hours stock price is 0.050 USD, the stock has decreased by -0.006, or -10.710%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.